SCHEMBL24405904

SCHEMBL24405904

Cn1c(=O)n(-c2ccnc(N3CCOCC3)c2)c2ccccc21

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LRRK2 Q5S007 9/20 0.55
▸ PIK3CA P42336 3/20 0.45
▸ MEN1 O00255 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ PIK3CD O00329 1/20 0.41
▸ PIK3CB P42338 1/20 0.41
▸ PIK3CG P48736 1/20 0.41
▸ RAF1 P04049 1/20 0.41
▸ BRAF P15056 1/20 0.41
▸ HRH4 Q9H3N8 1/20 0.40
▸ OPRD1 P41143 1/20 0.40
▸ KCNH2 Q12809 1/20 0.40
▸ SMG1 Q96Q15 1/20 0.39
▸ MAP4K1 Q92918 1/20 0.39
▸ MAPK8 P45983 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27936855 0.74 LRRK2 (0.59) LRRK2PIK3CAPIK3CDHRH4SMG1
SCHEMBL1269228 0.74 PGR (0.41) PIK3CAMEN1KMT2AKDM4EALDH1A1
SCHEMBL24405984 0.72 EED (0.45) PIK3CAMAP4K1MAPK8
SCHEMBL17573363 0.71 LRRK2 (1.00) LRRK2MAP4K1
SCHEMBL24406033 0.70 KMT2A (0.43) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL14094434 0.69 SMN1; SMN2 (0.47) ALDH1A1
SCHEMBL24405670 0.68 GAA (0.40) MEN1TSHRKMT2AKDM4EALDH1A1
SCHEMBL24406056 0.68 CNR2 (0.40) ALDH1A1HRH4
SCHEMBL17430354 0.68 LRRK2 (0.50) LRRK2PIK3CAMEN1KMT2AKDM4E
SCHEMBL827848 0.67 PIK3CA (0.58) LRRK2PIK3CAMEN1TSHRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3774739-B1 FUSED CYCLIC UREA DERIVATIVES AS CRHR2 ANTAGONIST RAQUALIA PHARMA INC (JP) 2022-05-11 — — EP disclosed
Send feedback